The performance of management and the BoD constantly needs to be re-evaluated and with the AGM coming up this is the time when shareholders get an opportunity to have their say. If there is an opportunity to strengthen our management team and BoD then tough decisions may need to be made. Just as you have the right to have your say on how this company is run, so do I, and so does every other shareholder of the company.
- Forums
- ASX - By Stock
- EGR
- Ann: Conference Presentation - 121 Mining Investment NY
Ann: Conference Presentation - 121 Mining Investment NY, page-16
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EGR (ASX) to my watchlist
|
|||||
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $54.48M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.5¢ | $38.08K | 325.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4500 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 104325 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4500 | 0.115 |
10 | 241000 | 0.110 |
8 | 137384 | 0.105 |
14 | 334594 | 0.100 |
1 | 140000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 104325 | 4 |
0.130 | 19999 | 1 |
0.135 | 10000 | 1 |
0.140 | 118506 | 3 |
0.145 | 24910 | 1 |
Last trade - 15.33pm 15/07/2024 (20 minute delay) ? |
Featured News
EGR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online